Jun 5, 2026 08:00AM
Jun 5, 2026 08:00AM
Jun 5, 2026 08:00AM
Jun 5, 2026 08:00AM
Jun 4, 2026 08:00AM
Jun 4, 2026 08:00AM
May 7, 2026 04:01PM Amneal Reports First Quarter 2026 Financial Results
Apr 22, 2026 06:00AM
Apr 22, 2026 06:00AM
Apr 20, 2026 08:02AM
Apr 20, 2026 08:00AM
Apr 14, 2026 08:00AM
Apr 9, 2026 08:00AM
Apr 7, 2026 04:01PM Amneal to Report First Quarter 2026 Results on May 1, 2026
Apr 7, 2026 08:00AM
Apr 7, 2026 08:00AM
Feb 27, 2026 06:35AM
Feb 27, 2026 06:00AM
Jan 27, 2026 08:00AM
Dec 22, 2025 04:01PM
Dec 22, 2025 04:01PM Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
Dec 9, 2025 04:01PM
Dec 9, 2025 04:01PM
Dec 5, 2025 08:02AM
Dec 5, 2025 08:00AM
Dec 2, 2025 08:00AM
Dec 2, 2025 08:00AM
Dec 1, 2025 04:01PM Amneal receives FDA approval for generic RESTASIS eye drops
Dec 1, 2025 04:01PM
Nov 13, 2025 04:01PM
Nov 13, 2025 04:01PM
Oct 30, 2025 06:04AM
Oct 30, 2025 06:00AM
Oct 29, 2025 04:09PM
Oct 29, 2025 04:05PM Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
Oct 27, 2025 08:00AM
Sep 30, 2025 04:05PM
Sep 26, 2025 08:02AM
Sep 26, 2025 08:00AM
Sep 23, 2025 08:00AM
Sep 23, 2025 08:00AM
Sep 11, 2025 08:00AM Amneal gets FDA approval for generic sodium oxybate oral solution
Sep 11, 2025 08:00AM
Sep 4, 2025 04:01PM
Sep 4, 2025 04:01PM
Aug 5, 2025 06:10AM
Aug 5, 2025 06:00AM
Jul 21, 2025 07:40AM
Jul 21, 2025 07:39AM Amneal seeks $1.8 billion term loan and $750 million bond offering
Jul 21, 2025 07:39AM

1,199,634 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All